XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
NOTE 9 - SHARE-BASED COMPENSATION
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]  
NOTE 9 - SHARE-BASED COMPENSATION

For share-based awards granted, we have recognized compensation expense based on the estimated grant date fair value method.  For these awards we have recognized compensation expense using a straight-line amortization method reduced for estimated forfeitures.  

 

The impact on our results of operations of recording share-based compensation, net of forfeitures, for the three and six months ended June 30, 2020 and 2019, respectively, were as follows:

   Three Months Ended  Six Months Ended
   June 30,
2020
  June 30,
2019
  June 30,
2020
  June 30,
2019
(in thousands)            
Cost of goods sold  $15   $10   $21   $16 
Research and development   132    103    196    166 
Selling, general and administrative   334    251    513    469 
Total share-based compensation  $481   $364   $730   $651 

 

Equity awards granted during the three and six months ended June 30, 2020 and 2019 were as follows:

 

   Three Months Ended  Six Months Ended
   June 30,
2020
  June 30,
2019
  June 30,
2020
  June 30,
2019
Restricted Stock Units   376,200    276,700    376,200    276,700 
Stock Options   —      25,000    —      25,000 

 

Non-employee directors Restricted Stock Units (“RSU’s”) vest over one year and options vest over three years and have a six-year exercise period.  Employee RSU’s typically vest over four years and employee Non-Qualified stock options typically vest quarterly over 4 years and have a six-year exercise period.

 

The remaining unamortized expected future equity compensation expense and remaining amortization period associated with unvested option grants, restricted stock awards and restricted stock unit awards at June 30, 2020 are:

 

   June 30,
2020
Unamortized future equity compensation expense (in thousands)  $2,731 
Remaining weighted average amortization period (in years)   2.63